Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Added funding, biosecurity measures and a vaccine rollout may be playing a major role in limiting disasters caused by ...

So far this year, influenza cases are nearly 20 per cent higher than they were last year, and 2,800 cases were recorded in ...

As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Influenza virus is an infectious agent belonging to the virus family Orthomyxoviridae that causes a respiratory tract infection (influenza or 'flu') in vertebrates. There are three main species ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

In parallel, Guyana began weekly reporting of surveillance data to the Pan American Health Organization (PAHO)/World Health Organization (WHO) via FluNet and ...

Apr. 4, 2025 — Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission.